mylan inc (MYL:NASDAQ GS)
Transactions by MYLAN INC (MYL) in the last 6 months
Mylan, Inc. (NasdaqGS:MYL) entered into a business transfer agreement to acquire non-U.S. developed markets specialty and branded generics business of Abbott Laboratories (NYSE:ABT) for approximately $5.3 billion on July 13, 2014. The assets are being acquired on a debt-free basis. In the transaction, Abbott will transfer the assets to Mylan in consideration for 105 million Mylan ordinary shares, representing 21% stake and Mylan will hold 71% stake. Under the agreement, ...
Mylan, Inc. (NasdaqGS:MYL) made an indicative proposal to acquire Meda AB (OM:MEDA A) on April 4, 2014.
Swedbank Robur Fonder AB
|Omnicare Inc||$62.90 USD||-0.34|
|Perrigo Co PLC||$147.27 USD||+0.63|
|UCB SA||€68.12 EUR||-0.15|
|WW Grainger Inc||$253.42 USD||+0.34|
|WESCO International Inc||$82.75 USD||-0.16|
|View Industry Companies|